ロード中...
Recent advances in managing axial spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory rheumatic disease that predominantly affects the axial skeleton. The advent of biologic drugs has transformed the management of patients with axSpA. However, non-steroidal anti-inflammatory drugs remain the first-line drug treatment for axSpA...
保存先:
| 出版年: | F1000Res |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
F1000 Research Limited
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7359748/ https://ncbi.nlm.nih.gov/pubmed/32704350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.22577.1 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|